TTX.AX Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: October 20, 2025
Report Source: 2025 Annual Report
Tetratherix Ltd. Stock Analysis TTX.AX
Tetratherix Ltd. engages in the development of a biostealth fluid matrix for regenerative medicine. The company is headquartered in Sydney, New South Wales. The company went IPO on 2025-06-30. The firm's biomaterial platform is built with polymer programming akin to Medical Lego to form implantable products to solve a range of clinical problems. The material is an injectable fluid to avoid causing damage to the body during its application. Upon injection, triggered by physiological temperature, a 3D matrix is formed that physically integrates and adheres to the target tissue. Tegenix and TegenEOS products are developed as a carrier designed to be mixed with a broad array of bone graft materials (BGMs) for dental, oral and orthopedic applications. TetraDerm products can be used in any surgical incision site to reduce scarring. Tutelix products are intended for use as a spacer to reduce side effects from radiation therapy in prostate cancer. The company has established its manufacturing center in Sydney, featuring a cleanroom production facility.
Read More Tetratherix Ltd (TTX.AX) Chart
Key Statistics of Tetratherix Ltd (TTX.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD4.97Volume
17.00P/E Ratio (TTM)
-52 Week Range
Market Cap
244.18MAvg. Volume
-Dividend Yield
-Financial Metrics & Statements of Tetratherix Ltd (TTX.AX)
FAQ's for Tetratherix Ltd (TTX.AX)
- According to Musaffa’s Shariah screening methodology, Tetratherix Ltd (TTX.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.